Different molecular patterns in glioblastoma multiforme subtypes upon recurrence
Open Access
- 31 July 2009
- journal article
- research article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 96 (3) , 321-329
- https://doi.org/10.1007/s11060-009-9967-4
Abstract
One of the hallmarks of glioblastoma is its inherent tendency to recur. At this point patients with relapsed GBM show a survival time of only few months. The molecular basis of the recurrence process in GBM is still poorly understood. The aim of the present study was to investigate the genetic profile of relapsed GBM compared to their respective primary tumors. We have included 20 paired GBMs. In all tumor samples, we have analyzed p53 and PTEN status by sequencing analysis, EGFR amplification by semiquantitative PCR and a wide-genome fingerprinting was performed by microsatellite analysis. Among primary GBM, we observed twelve type 2 GBM, four type 1 GBM and four further GBM showing neither p53 mutations nor EGFR amplification (non-type 1–non-type 2 GBM). Upon recurrence, we have detected two molecular patterns of tumor progression: GBM initially showing either type 1 or type 2 profiles conserved them at the time of relapse. In contrast, non-type 1–non-type 2 GBM acquired the typical pattern of type 2 GBM and harbor EGFR amplification without p53 mutation. New PTEN mutations upon relapse were only detected in type 2 GBM. Additional LOH were more frequently identified in relapses of type 2 GBM than in those showing the type 1 signature. Taken together, our results strongly suggest that recurrences of GBM may display two distinct pattern of accumulation of molecular alterations depending on the profile of the original tumor.Keywords
This publication has 43 references indexed in Scilit:
- Comprehensive genomic characterization defines human glioblastoma genes and core pathwaysNature, 2008
- Genetic Pathways to Primary and Secondary GlioblastomaThe American Journal of Pathology, 2007
- Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastomaBritish Journal of Cancer, 2007
- Mutation-Positive and Mutation-Negative Patients with Cowden and Bannayan-Riley-Ruvalcaba Syndromes Associated with Distinct 10q HaplotypesAmerican Journal of Human Genetics, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- The codon 72 polymorphic variants of p53 have markedly different apoptotic potentialNature Genetics, 2003
- Rare‐type Mutations of MMAC1 Tumor Suppressor Gene in Human Glioma Cell Lines and Their Tumors of OriginJapanese Journal of Cancer Research, 1999
- Comparative molecular genetic profiles of anaplastic astrocytomas/ glioblastomas multiforme and their subsequent recurrencesOncogene, 1999
- Clonal analysis of human astrocytomasJournal of Neuro-Oncology, 1994
- Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after SurgeryNew England Journal of Medicine, 1980